Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers 2024-06-22
  2. Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease:a systematic review with meta-analysis 2022-03-03
  3. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up 2016-08-17

Studies

3 studies carry this tag.

Date range

2016 to 2024

Top journals

  • Cells 1
  • Journal of neurology, neurosurgery, and psychiatry 1
  • Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Cells 2024-06-22 Biomarkers

    This prospective cohort study revealed that plasma NFL may predict longitudinal declines in Mini-Mental State Examination (MMSE) scores.

  2. Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease:a systematic review with meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 81 out of 100. Journal of neurology, neurosurgery, and psychiatry 2022-03-03 Biomarkers

    Plasma Aβ40 values might not distinguish between PET (+) and PET (-) people.

  3. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Neurology 2016-08-17 Biomarkers

    These findings suggest that a simple blood-based signature not only provides estimates of NAB but also predicts cognitive decline and disease progression, identifying individuals at risk of progressing toward AD at the prodromal and preclinical stages.

All topic tags with their study counts